TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
2.060
-0.040 (-1.90%)
At close: Sep 1, 2026, 4:00 PM EDT
2.030
-0.030 (-1.46%)
After-hours: Sep 1, 2026, 7:56 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $34.88 million as of September 1, 2026. Its market cap has increased by 329.96% in one year.
Market Cap
34.88M
Enterprise Value
27.15M
1-Year Change
329.96%
Ranking
Category
Stock Price
$2.06
ChartMarket Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $34.88M, a decrease of -27.14%. That is a compound annual growth rate of -5.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 34.88M | 456.89% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 42.41M |
| Mereo BioPharma Group | 40.32M |
| Actuate Therapeutics | 39.74M |
| CervoMed | 39.31M |
| Context Therapeutics | 35.25M |
| Quince Therapeutics | 34.33M |
| Veraxa Biotech AG | 34.04M |
| Lite Strategy | 33.36M |